VIRGINIA RETIREMENT SYSTEMS ET AL - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 291 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 1.33 and the average weighting 0.2%.

Quarter-by-quarter ownership
VIRGINIA RETIREMENT SYSTEMS ET AL ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$562,428
+1.7%
20,400
+10.9%
0.01%
+20.0%
Q2 2023$553,104
+50.7%
18,400
+46.0%
0.01%
+66.7%
Q4 2021$367,000
-40.9%
12,600
-45.9%
0.00%
-50.0%
Q3 2021$621,000
-30.0%
23,300
-19.1%
0.01%
-33.3%
Q2 2021$887,000
+9.0%
28,800
-7.4%
0.01%
+12.5%
Q1 2021$814,000
-8.3%
31,100
-11.9%
0.01%
-11.1%
Q4 2020$888,000
+8.4%
35,300
-10.2%
0.01%0.0%
Q3 2020$819,000
-15.0%
39,300
-3.2%
0.01%
-18.2%
Q2 2020$964,000
+20.3%
40,600
-8.8%
0.01%0.0%
Q1 2020$801,000
-24.1%
44,5000.0%0.01%0.0%
Q4 2019$1,056,000
-13.4%
44,500
+0.2%
0.01%
-21.4%
Q3 2019$1,220,000
+43.5%
44,400
+72.8%
0.01%
+40.0%
Q2 2019$850,000
-28.9%
25,700
-24.6%
0.01%
-28.6%
Q1 2019$1,195,000
+10.6%
34,100
+4.9%
0.01%
-6.7%
Q4 2018$1,080,000
+30.0%
32,500
+97.0%
0.02%
+50.0%
Q3 2018$831,000
-39.1%
16,500
-27.6%
0.01%
-41.2%
Q2 2018$1,365,000
+0.4%
22,800
-23.2%
0.02%
+6.2%
Q1 2018$1,360,000
-26.9%
29,700
-36.4%
0.02%
-27.3%
Q4 2017$1,861,000
-10.5%
46,700
-10.2%
0.02%
-12.0%
Q3 2017$2,080,000
-29.2%
52,000
-23.8%
0.02%
-32.4%
Q2 2017$2,939,000
+30.8%
68,200
-5.0%
0.04%
+27.6%
Q1 2017$2,247,000
+45.2%
71,800
+17.1%
0.03%
+31.8%
Q4 2016$1,548,000
+9.8%
61,300
+7.5%
0.02%
+10.0%
Q3 2016$1,410,000
+502.6%
57,000
+395.7%
0.02%
+566.7%
Q2 2016$234,00011,5000.00%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q3 2018
NameSharesValueWeighting ↓
ASHFORD CAPITAL MANAGEMENT INC 698,676$41,816,0005.51%
Provident Investment Management, Inc. 543,194$32,510,0004.61%
NEUMEIER POMA INVESTMENT COUNSEL LLC 426,250$25,511,0002.37%
KOPP INVESTMENT ADVISORS LLC 41,879$2,506,0002.35%
AlphaOne Investment Services, LLC 126,279$7,558,0002.17%
Ranger Investment Management 468,933$28,066,0001.96%
Bruce & Co., Inc. 158,058$9,459,0001.88%
Penserra Capital Management LLC 244,371$29,030,0001.83%
SHAKER INVESTMENTS LLC/OH 49,642$2,971,0001.83%
Bridge City Capital, LLC 47,795$2,861,0001.81%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders